🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exercise as Treatment of Fatigue in Parkinson´s Disease

RecruitingNAAges 40 Years - anyAllUniversity of Aarhus
NCT06324422 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary goal of this study is to test whether 12 weeks of high-intensity aerobic exercise can treat fatigue in Parkinsons disease (PD). The study will be a randomized multi-site controlled trial with follow up. Clinically fatigued persons with PD will be allocated to either 12 weeks of high-intensity aerobic exercise or to a waitlist control group receiving high-intensity resistance exercise after 24 weeks of habitual lifestyle (control period). It is hypothesized that persons with PD receiving 12 weeks of high-intensity aerobic exercise will show superior effects on perceived fatigue (i.e., clinical relevant reductions) when compared to the PD control group (primary hypothesis), and that these effects are sustained after 12-weeks of follow up (secondary hypothesis).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Minimum 40 years * Diagnosed with Idiopathic Parkinsons disease * Stable in medical treatment for six month * Able to transport themselves to and from exercise and testing sessions (with or without assistance) * H\&Y score of three or lower Exclusion criteria: * Performing high-intensity exercise more than two times per week * Significant medical comorbidities such as cardiovascular, respiratory, orthopedic, metabolic, or other neurological disorders * Cognitive dysfunction that prevents following or understanding instructions related to training and testing (answering questionnaires) * Known depression or alcohol abuse
💊

What it tests

  • Aerobic exercise intervention
  • Resistance exercise intervention
📍

Where

1 site
Exercise Biology, Dep. of Public Health, Aarhus University
Aarhus, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy